Capital International Investors Invests $707.67 Million in Humana Inc. $HUM

Key Points

• Capital International Investors bought 2,720,437 shares of Humana—about 2.26% of the company—worth approximately $707.67 million in the third quarter, according to its latest 13F filing.
• Several analysts have trimmed price targets on Humana and the stock carries a consensus rating of "Hold" with a consensus price target of $225.48.
• Humana announced a quarterly dividend of $0.885 (annualized $3.54), a yield of roughly 2.0%, with an ex-dividend/record date on March 27 and payment on April 24.

Capital International Investors acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,720,437 shares of the insurance provider's stock, valued at approximately $707,670,000. Capital International Investors owned approximately 2.26% of Humana as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Elevation Point Wealth Partners LLC acquired a new stake in Humana in the 2nd quarter worth approximately $32,000. Mather Group LLC. acquired a new position in Humana during the 3rd quarter valued at approximately $34,000. Private Wealth Management Group LLC raised its holdings in shares of Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock worth $39,000 after buying an additional 48 shares during the last quarter. AlphaCore Capital LLC purchased a new position in shares of Humana in the second quarter worth $39,000. Finally, SJS Investment Consulting Inc. lifted its stake in shares of Humana by 19,300.0% during the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider's stock worth $50,000 after buying an additional 193 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Humana

In other Humana news, insider Sanjay K. Shetty bought 810 shares of Humana stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $185.21 per share, with a total value of $150,020.10. Following the purchase, the insider directly owned 11,657 shares in the company, valued at $2,158,992.97. This represents a 7.47% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.37% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Raymond James Financial dropped their price objective on shares of Humana from $340.00 to $230.00 and set an "outperform" rating on the stock in a report on Friday, February 13th. Barclays reduced their target price on Humana from $245.00 to $176.00 and set an "equal weight" rating for the company in a research note on Tuesday, February 24th. Sanford C. Bernstein reiterated an "outperform" rating and set a $344.00 price target on shares of Humana in a research note on Tuesday, January 6th. TD Cowen cut their price objective on Humana from $260.00 to $173.00 and set a "hold" rating on the stock in a report on Friday, February 13th. Finally, JPMorgan Chase & Co. reduced their price objective on Humana from $274.00 to $180.00 and set a "neutral" rating for the company in a research note on Friday, February 13th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $225.48.

Humana Trading Down 2.8%

HUM stock opened at $173.58 on Wednesday. The company's 50-day simple moving average is $218.44 and its 200-day simple moving average is $250.29. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana Inc. has a 52-week low of $169.61 and a 52-week high of $315.35. The firm has a market cap of $20.84 billion, a P/E ratio of 17.68, a PEG ratio of 1.83 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating the consensus estimate of ($4.01) by $0.05. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.Humana's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.885 dividend. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. Humana's payout ratio is 36.05%.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.